Search This Blog

Tuesday, January 18, 2022

Neurocrine cut to Sector Perform from Outperform by RBC

 Target to $90 from $122

https://finviz.com/quote.ashx?t=NBIX&ty=c&ta=1&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.